35
Participants
Start Date
September 10, 2023
Primary Completion Date
September 10, 2024
Study Completion Date
September 10, 2026
Propofol
Anesthesia will be induced intravenously using the hypnotic drug propofol. The drug is used regularly in everyday clinical practice to carry out general anesthesia, and the intended concentrations are within the usual clinical dosage range. Propofol will be applied via target-controlled infusion (TCI) with a perfusor using TCI set to effect mode as described by Schnider (Schnider et al., 2016). Starting at low concentrations, the effect site concentration will be increased stepwise to achieve the target level of sedation as measured by the Modified Observer's Assessment of Alertness and Sedation (MOAA/S) scale. We aim for three different levels of sedation: low (MOAA/S=5-4), mid (MOAA/S=3-2) and high (MOAA/S=1).
visual flickering stimulation at the alpha frequency
Participants will receive visual stimulation as a flickering light during the different sedation levels, including wakefulness pre- and post-anesthesia. Stimulation will be done with eyes closed in all conditions.
RECRUITING
Technische Universität München, München
RECRUITING
Klinikum rechts der Isar - Klinik für Anästhesiologie und Intensivmedizin, Munich
Technical University of Munich
OTHER